← Back to patent-cliff list
CAS 1044872-73-2
4-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-3,5-dimethylbenzaldehyde
Codes: APAB-005
Application context (from source-drug indications)
新冠后遗症ApabetaloneEnd-stage renal diseaseApabetalonePulmonary arterial hypertensionApabetaloneFabry diseaseApabetaloneCOVID-19ApabetaloneDyslipidaemiaApabetalone
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Apabetalone | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-amino-4,6-dimethoxybenzamide→4-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-3,5-dimethylbenzaldehyde
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.